Cargando…
Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress
Glaucoma is a leading cause of irreversible visual impairment and blindness, affecting over 76.0 million people worldwide in 2020, with a predicted increase to 111.8 million by 2040. Hypotensive eye drops remain the gold standard for glaucoma treatment, while inadequate patient adherence to medicati...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999627/ https://www.ncbi.nlm.nih.gov/pubmed/36899348 http://dx.doi.org/10.1186/s12951-023-01838-x |